Pfizer, BioNTech Pledge 2 Billion Vaccine Doses to Poor Nations

U.S. and German vaccine partners Pfizer and BioNTech on Friday pledged to deliver 2 billion doses of their vaccine to low- and middle-income nations as part of a global effort to close the vaccine gap between rich and poor nations.

Pfizer CEO Albert Bourla, speaking in Rome at the Global Health Summit, said the first billion doses of their vaccine will be delivered this year, and the second in 2022. U.S. pharmaceutical companies Moderna and Johnson & Johnson also pledged donations of 200,000 and 100,000 doses respectively. Tentative reopenings